AIM ImmunoTech
AIM ImmunoTech Inc. (AMEX: AIM), formerly known as Hemispherx Biopharma Inc., is a biopharmaceutical company based in Ocala, Florida. focused on the research and development of therapeutics to treat multiple types of cancers, various viruses and immune-deficiency disorders. Founded in 1990, the company has 23 employees. The company has created an immunomodulatory double stranded RNA drug called Ampligen. The company is developing Ampligen to use as a treatment for multiple cancer tumor types, COVID-19 and chronic fatigue syndrome.
primaryTopic
AIM ImmunoTech
AIM ImmunoTech Inc. (AMEX: AIM), formerly known as Hemispherx Biopharma Inc., is a biopharmaceutical company based in Ocala, Florida. focused on the research and development of therapeutics to treat multiple types of cancers, various viruses and immune-deficiency disorders. Founded in 1990, the company has 23 employees. The company has created an immunomodulatory double stranded RNA drug called Ampligen. The company is developing Ampligen to use as a treatment for multiple cancer tumor types, COVID-19 and chronic fatigue syndrome.
has abstract
AIM ImmunoTech Inc. (AMEX: AIM ...... and chronic fatigue syndrome.
@en
assets ($)
industry
location city
państwo
Link from a Wikipage to an external page
Wikipage page ID
page length (characters) of wiki page
Wikipage revision ID
1,018,870,210
Link from a Wikipage to another Wikipage
assets
assets year
hq location city
hq location country
industry
key people
CEO Thomas K. Equels, J.D.
@en
CFO Ellen Lintal
@en
COO Peter W. Rodino III, J.D.
@en
logo
@en
logo caption
AIM ImmunoTech company logo.
@en
name
AIM ImmunoTech
@en
products
trade name
AIM
@en
traded as
AMEX:AIM
@en
wikiPageUsesTemplate
subject
comment
AIM ImmunoTech Inc. (AMEX: AIM ...... and chronic fatigue syndrome.
@en
label
AIM ImmunoTech
@en
wasDerivedFrom
homepage
isPrimaryTopicOf
name
AIM ImmunoTech
@en